Effect of alphapinen addition to pharmacotherapy regimen of ulcerative colitis patients
Phase 3
Recruiting
- Conditions
- Ptients with diagnosis of ulcerative colitis.Ulcerative colitis, unspecifiedK51.9
- Registration Number
- IRCT20121021011192N17
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients with diagnosis of ulcerative colitis on the basis of doing colonpscopy Obtaining written informed consent
Exclusion Criteria
Patients with previous history of allergy to alphapinen
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method